These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Syndromes of glucocorticoid and mineralocorticoid resistance. Zennaro MC Eur J Endocrinol; 1998 Aug; 139(2):127-38. PubMed ID: 9724063 [No Abstract] [Full Text] [Related]
3. The mechanisms of differential glucocorticoid and mineralocorticoid action in the brain and peripheral tissues. Rashid S; Lewis GF Clin Biochem; 2005 May; 38(5):401-9. PubMed ID: 15820768 [TBL] [Abstract][Full Text] [Related]
6. Pseudohypoaldosteronism: severe salt wasting in infancy caused by generalized mineralocorticoid unresponsiveness. Savage MO; Jefferson IG; Dillon MJ; Milla PJ; Honour JW; Grant DB J Pediatr; 1982 Aug; 101(2):239-42. PubMed ID: 7097421 [No Abstract] [Full Text] [Related]
7. [New data on mineralocorticoid hormones. Physiopathological implications]. Corvol P; Jeunemaitre X Presse Med; 1995 Sep; 24(27):1235-7. PubMed ID: 7501603 [TBL] [Abstract][Full Text] [Related]
8. Inherited forms of mineralocorticoid hypertension. Hassan-Smith Z; Stewart PM Curr Opin Endocrinol Diabetes Obes; 2011 Jun; 18(3):177-85. PubMed ID: 21494136 [TBL] [Abstract][Full Text] [Related]
9. Effects of acute mineralocorticoid and glucocorticoid receptor blockade on the excretion of an acute potassium load in healthy humans. van Buren M; Boer P; Koomans HA J Clin Endocrinol Metab; 1993 Oct; 77(4):902-9. PubMed ID: 8408463 [TBL] [Abstract][Full Text] [Related]
10. The determination of mineralocorticoid receptors in human mononuclear leukocytes from patients with mineralocorticoid excess: physiological and pathological implications. Armanini D; Kuhnle U; Witzgall H; Tietze U; Saule H; Schroeter C; Strasser T; Butenandt I; Bidlingmaier F; Weber PC Clin Exp Hypertens A; 1986; 8(4-5):781-5. PubMed ID: 3019593 [TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. Kino T; Chrousos GP J Endocrinol; 2001 Jun; 169(3):437-45. PubMed ID: 11375113 [TBL] [Abstract][Full Text] [Related]
12. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Oitzl MS; de Kloet ER Behav Neurosci; 1992 Feb; 106(1):62-71. PubMed ID: 1313244 [TBL] [Abstract][Full Text] [Related]
13. New insights into glucocorticoid and mineralocorticoid signaling: lessons from gene targeting. Reichardt HM; Tronche F; Berger S; Kellendonk C; Schütz G Adv Pharmacol; 2000; 47():1-21. PubMed ID: 10582083 [No Abstract] [Full Text] [Related]
15. Glucocorticoids and 11β-hydroxysteroid dehydrogenases: mechanisms for hypertension. Hunter RW; Bailey MA Curr Opin Pharmacol; 2015 Apr; 21():105-14. PubMed ID: 25666420 [TBL] [Abstract][Full Text] [Related]
16. Expression patterns of mineralocorticoid and glucocorticoid receptors in Bengalese finch (Lonchura striata var. domestica) brain suggest a relationship between stress hormones and song-system development. Suzuki K; Matsunaga E; Kobayashi T; Okanoya K Neuroscience; 2011 Oct; 194():72-83. PubMed ID: 21851851 [TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. Funder JW Annu Rev Med; 1997; 48():231-40. PubMed ID: 9046958 [TBL] [Abstract][Full Text] [Related]
18. Two uncommon causes of mineralocorticoid excess. Syndrome of apparent mineralocorticoid excess and glucocorticoid-remediable aldosteronism. Ulick S Endocrinol Metab Clin North Am; 1991 Jun; 20(2):269-76. PubMed ID: 1879399 [TBL] [Abstract][Full Text] [Related]
19. Liquorice: new insights into mineralocorticoid and glucocorticoid hypertension. Morris DJ R I Med; 1993 May; 76(5):251-4. PubMed ID: 8518501 [No Abstract] [Full Text] [Related]
20. Mineralocorticoid receptors, salt, and hypertension. Funder JW; Krozowski Z; Myles K; Sato A; Sheppard KE; Young M Recent Prog Horm Res; 1997; 52():247-60; discussion 261-2. PubMed ID: 9238855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]